Skip to content

Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software

Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05389072
Enrollment
57
Registered
2022-05-24
Start date
2022-06-01
Completion date
2023-05-31
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

As new orthokeratology fitting software emerges onto the market, it is of interest to assess their usefulness in guiding eye practitioners with lens fit. The goal of this study is to evaluate the comfort of Paragon orthokeratology lenses when they are fit using the new Procornea software.

Interventions

control CRT lens

Sponsors

CooperVision, Inc.
CollaboratorINDUSTRY
CooperVision International Limited (CVIL)
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Are 6- 35 years of age 2. Have had a self-reported visual exam in the last two years 3. Have a contact lens refraction that fits within the available parameters of the study lenses 4. Are able to read (or be read to), understand and sign the assent document if under 18 years old or are able to read, understand and sign the consent document if aged 18 or older (Children 6-years of age will not be asked to sign the assent form as per STERLING IRB.); 5. Are under 18 years old and are accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document; 6. Are willing to comply with the wear schedule (8 hour per night for every night, while sleeping) 7. Are willing to comply with the visit schedule 8. Have a refractive spherical component of their prescription between -0.50 and up to -6.00 diopters (inclusive) AND a refractive cylinder of no more than -1.75 diopters 9. Have a refractive spherical component ≥ cylinder component 10. Have a minimum visual acuity of +0.20 logMAR with each eye, when refracted at the Screening visit 11. Have clear corneas and no active ocular disease 12. Have no medication, medical condition, or ocular conditions that contraindicate contact wear OR are expected to affect lens comfort or vision across the 1-month study duration, in the opinion of the investigator 13. Can be shown to have stable keratometry for at least the previous 1 month, if they have previously worn orthokeratology lenses.

Exclusion criteria

1. Present at screening visit with the presence of ocular or systemic disease or reports the use medications which might interfere with orthokeratology contact lens wear, such as keratoconus, diabetes mellitus, steroid eye drops 2. Have a post-treatment predicted flat K value ≤38.00D (e.g. Patient baseline flat keratometry value = 40.00, patient has 2.00D of myopic refractive error. 40.00-2.00= 38.00D) 3. Have a known sensitivity to the diagnostic sodium fluorescein to be used in the study 4. Are pregnant, planning a pregnancy or lactating 5. Have amblyopia 6. Have presbyopia or has dependence on spectacles for near work over the contact lenses 7. Present at screening visit with the presence of clinically significant (grade \>3; Efron scale) anterior segment abnormalities. 8. Present at screening visit with slit lamp findings that would contraindicate orthokeratology contact lens wear such as: 1. Pathological dry eye or associated findings 2. Pterygium, pinguecula, or corneal scars within the visual axis 3. Neovascularization \> 0.75 mm from of the limbus 4. Giant papillary conjunctivitis (GPC) worse than grade 1 5. Anterior uveitis or iritis (past or present) 6. Seborrheic eczema, Seborrheic conjunctivitis 7. History of corneal ulcers or fungal infections 8. Poor personal hygiene 9. Aphakia

Design outcomes

Primary

MeasureTime frameDescription
Comfort1 weekComfort of lenses (VAS 0-10, 0,5 steps) after insertion, subjects will be graded on a scale from 0 to 10 with 0=painful, 10= can't feel the lenses

Countries

Spain, United States

Contacts

Primary ContactJose Vega, OD
jvega2@coopervision.com925-621-3761
Backup ContactKelly Voltz, OD
kvoltz@coopervisionsec.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026